Titration of amlodipine to higher doses: a comparison of Asian and Western experience

References

• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034261206125214656957
   PubMed Web of Science ®Google Scholar
• VasanRSLarsonMGLeipEPImpact of high-normal blood pressure on the risk of cardiovascular diseaseN Engl J Med2001345181291129711794147
   PubMed Web of Science ®Google Scholar
• LewingtonSClarkeRQizilbashNPetoRCollinsRAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet200236093491903191312493255
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA2002288232998300712479764
   PubMed Web of Science ®Google Scholar
• DahlöfBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet2005366948989590616154016
   PubMed Web of Science ®Google Scholar
• OgiharaTNakaoKFukuiTEffects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trialHypertension200851239339818172059
   PubMed Web of Science ®Google Scholar
• LawMRMorrisJKWaldNJUse of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ2009338b166519454737
   PubMed Web of Science ®Google Scholar
• CostanzoPPerrone-FilardiPPetrettaMCalcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patientsJ Hypertens20092761136115119451836
   PubMed Web of Science ®Google Scholar
• TakagiHUmemotoTRevisiting evidence of blood pressure-dependent and independent effects of amlodipine on the risk of strokeJ Clin Hypertens (Greenwich)2011131078178221974768
   PubMed Web of Science ®Google Scholar
• WangJGLiYFranklinSSSafarMPrevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overviewHypertension200750118118817502490
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA2002288232981299712479763
   PubMed Web of Science ®Google Scholar
• DaskalopoulouSSKhanNAQuinnRRThe 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapyCan J Cardiol201228327028722595447
   PubMed Web of Science ®Google Scholar
• ManciaGLaurentSAgabiti-RoseiEReappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documentBlood Press200918630834720001654
   PubMed Web of Science ®Google Scholar
• WangJGKarioKLauTUse of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart AssociationHypertens Res201134442343021228778
   PubMed Web of Science ®Google Scholar
• MartiniukALLeeCMLawesCMHypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific regionJ Hypertens2007251737917143176
   PubMed Web of Science ®Google Scholar
• LawesCMRodgersABennettDABlood pressure and cardiovascular disease in the Asia Pacific regionJ Hypertens200321470771612658016
   PubMed Web of Science ®Google Scholar
• PerkovicVHuxleyRWuYPrabhakaranDMacMahonSThe burden of blood pressure-related disease: a neglected priority for global healthHypertension200750699199717954719
   PubMed Web of Science ®Google Scholar
• FogariRMugelliniADerosaGEfficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertensionJRAAS20078313914417907102
   PubMedGoogle Scholar
• NissenSETuzcuEMLibbyPEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA2004292182217222515536108
   PubMed Web of Science ®Google Scholar
• KarioKOdawaraMKimuraKNodeKNearly half of uncontrolled hypertensive patients could be controlled by high-dose titration of amlodipine in the clinical setting: the ACHIEVE studyCurr Hypertens Rev20117102110
   Google Scholar
• UnoHIshikawaJHoshideSEffects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patientsHypertens Res200831588789618712044
   PubMed Web of Science ®Google Scholar
• WeirMRIncidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significanceJ Clin Hypertens (Greenwich)20035533033514564133
   PubMedGoogle Scholar
• ChockalingamACampbellNRFodorJGWorldwide epidemic of hypertensionCan J Cardiol200622755355516755308
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
   PubMed Web of Science ®Google Scholar
• LangdonCTreatment of hypertension in patients ≥65 years of age: experience with amlodipineClin Ther200022121473148211192138
   PubMed Web of Science ®Google Scholar
• TallianKBNahataMCTurmanMAMahanJDHayesJRMentserMIEfficacy of amlodipine in pediatric patients with hypertensionPediatr Nephrol199913430431010454779
   PubMed Web of Science ®Google Scholar
• ValcárcelYJiménezRHernándezVArísteguiRGilAEfficacy and safety of amlodipine: a comparative study of hypertensive patients treated at primary- and specialised-care centresClin Drug Investig2006263125133
   PubMed Web of Science ®Google Scholar
• SowunmiAWalkerOSalakoLAAmlodipine as monotherapy in hypertensive Africans: clinical efficacy and safety studiesAfr J Med Med Sci199625321321610457792
   PubMedGoogle Scholar
• JorgensenBSimonsenSEndresenKRestenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES)J Am Coll Cardiol200035359259910716459
   PubMed Web of Science ®Google Scholar
• MasonRPMechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidenceAtherosclerosis2002165219119912417269
   PubMed Web of Science ®Google Scholar
• HoshideSFukutomiMEguchiKWatanabeTKabutoyaTKarioKChange in high-sensitive cardiac troponin T on hypertensive treatmentClin Exp Hypertens2013351404422631049
   PubMed Web of Science ®Google Scholar
• KarioKMatsuoTKobayashiHImiyaMMatsuoMShimadaKNocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippersHypertension19962711301358591875
   PubMed Web of Science ®Google Scholar
• KarioKPickeringTGMatsuoTHoshideSSchwartzJEShimadaKStroke prognosis and abnormal nocturnal blood pressure falls in older hypertensivesHypertension200138485285711641298
   PubMed Web of Science ®Google Scholar
• KarioKPickeringTGUmedaYMorning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective studyCirculation2003107101401140612642361
   PubMed Web of Science ®Google Scholar
• KarioKMorning surge in blood pressure and cardiovascular risk: evidence and perspectivesHypertension201056576577320937968
   PubMed Web of Science ®Google Scholar
• IshimitsuTMinamiJKawanoYNumabeATakishitaSMatsuokaHAmlodipine, a long-acting calcium channel blocker, attenuates morning blood pressure rise in hypertensive patientsClin Exp Pharmacol Physiol199926750050410405773
   PubMed Web of Science ®Google Scholar
• EguchiKKarioKShimadaKEffects of long-acting ACE inhibitor (temocapril) and long-acting Ca channel blocker (amlodipine) on 24-h ambulatory BP in elderly hypertensive patientsJ Hum Hypertens200115964364811550111
   PubMed Web of Science ®Google Scholar
• FukutomiMHoshideSEguchiKWatanabeTShimadaKKarioKDifferential effects of strict blood pressure lowering by losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy on microalbuminuria: the ALPHABET studyJ Am Soc Hypertens201261738222054782
   PubMed Web of Science ®Google Scholar
• IshikawaJHoshideSEguchiKIshikawaSShimadaKKarioKNighttime home blood pressure and the risk of hypertensive target organ damageHypertension201260492192822892810
   PubMed Web of Science ®Google Scholar
• KarioKShimadaKDifferential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressureAm J Hypertens19971032612689056682
   PubMed Web of Science ®Google Scholar
• NielsenHeadaches, colds and backache – most common health complaints: Nielsen Global Survey2007 Available from: http://nz.nielsen.com/news/OTC_Aug07.shtmlAccessed July 29, 2013
   Google Scholar